Neonatal herpes simplex virus (HSV) infection
Treat empirically, low threshold · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Neonatal HSV presents as skin-eye-mouth (SEM), CNS, or disseminated disease, usually within the first 4 weeks of life, and can be rapidly fatal with high-dose IV aciclovir the cornerstone. Because mortality and neurodisability rise with any delay and many mothers are asymptomatic, treat empirically on suspicion while awaiting confirmation.
Red flags
- Seizures, encephalopathy or bulging fontanelle
- Vesicular rash (may be absent in up to a third)
- Coagulopathy, deranged LFTs or shock (disseminated disease)
- Maternal genital HSV (especially primary infection near delivery)
- Any deterioration while on antibiotics alone
Assessment
Differential diagnosis
- Bacterial early/late-onset sepsis
- Enteroviral/parechovirus sepsis
- Other congenital (TORCH) infection
- Metabolic/inborn error with encephalopathy
- Non-infective causes of neonatal seizures/hepatitis
Investigations
- HSV PCR from blood, CSF, and surface swabs (skin vesicles, eyes, mouth, nasopharynx, rectum)
- Lumbar puncture: CSF HSV PCR, cell count, protein, glucose
- LFTs and coagulation (disseminated disease causes hepatitis/coagulopathy)
- FBC, CRP, blood culture and full bacterial sepsis screen
- EEG and cranial MRI for CNS disease
- Ophthalmology review for keratoconjunctivitis
Management
- Have a low threshold — consider HSV in any unwell neonate with sepsis, seizures, hepatitis, coagulopathy or vesicles
- Start high-dose IV aciclovir empirically without waiting for PCR results
- Take HSV PCR from blood, CSF and all surface sites, plus LFTs and coagulation, before/at starting treatment
- Perform a lumbar puncture unless clinically contraindicated
- Continue broad-spectrum antibiotics until bacterial sepsis excluded
- Support organ dysfunction — correct coagulopathy, manage seizures and liver failure
- Treat SEM disease for 14 days and CNS/disseminated disease for a minimum of 21 days IV
- Repeat CSF HSV PCR near the end of treatment in CNS disease — continue aciclovir until PCR negative
- Ensure adequate hydration and monitor renal function (aciclovir nephrotoxicity)
- On completing IV therapy, start oral aciclovir suppression for 6 months to improve neurodevelopmental outcome
Drugs & doses
Aciclovir 20 mg/kg/dose IV every 8 hours (14 days SEM; >=21 days CNS/disseminated)
Oral aciclovir suppression 300 mg/m2/dose three times daily for 6 months after IV course
Benzylpenicillin + gentamicin empirically until bacterial sepsis excluded
Ensure IV hydration; adjust aciclovir dosing interval for renal impairment
Disposition
Admit to NICU with infectious diseases input; IV aciclovir and supportive care. Neurodevelopmental, ophthalmology and audiology follow-up after discharge.
Complications & pitfalls
- Death (high in untreated disseminated disease)
- Severe neurodevelopmental impairment and epilepsy
- Recurrent skin/eye disease
- Liver failure and DIC
- Aciclovir-related neutropenia/nephrotoxicity
Exam pearls
- Absence of a rash and absence of maternal history do NOT exclude neonatal HSV
- Start aciclovir empirically — do not wait for PCR in a sick neonate
- Confirm CSF HSV PCR negativity at end of CNS treatment before stopping IV aciclovir
- Six months of oral suppression improves neurodevelopmental outcomes after CNS disease
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.